What are Pacira BioSciences, Inc.'s profit margins?

Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.

Where do Pacira BioSciences, Inc.'s ratios come from?

Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Pacira BioSciences, Inc. PCRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	79.4%+3.7pp	75.7%+3.0pp	72.6%+2.5pp	70.1%-4.0pp
Operating margin	2.6%—	——	13%—	——
Net margin	1%—	——	6.2%—	——
Returns
Return on equity	1%—	——	5.1%—	——
Return on invested capital	1.9%—	——	6.3%—	——
Efficiency
Asset turnover	0.5×+0.1×	0.4×0.0×	0.4×+0.1×	0.4×0.0×
Liquidity
Current ratio	4.5×+2.1×	2.4×-2.8×	5.2×+1.9×	3.4×+1.7×
Leverage
Debt-to-equity	0.6×-0.1×	0.7×+0.5×	0.2×-0.2×	0.4×-0.6×
Net debt / EBITDA	2.4×—	——	0.2×—	——
Per Share
Book value per share	$15.39-8.6%	$16.83+0.5%	$16.74+0.5%	$16.65+4.0%
Valuation
Market capitalization	$942.78M-16.0%	$869.9M-44.5%	$1.57B-11.6%	$1.77B-33.9%
Price / earnings	183.5×—	——	37.3×—	——
Price / sales	1.3×-0.3×	1.2×-1.1×	2.3×-0.3×	2.7×-2.3×
Price / book	1.4×0.0×	1.1×-0.7×	1.8×-0.5×	2.3×-1.4×
EV / EBITDA	10.5×—	——	9.8×—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Pacira BioSciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Pacira BioSciences, Inc.'s profit margins?: Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.
Where do Pacira BioSciences, Inc.'s ratios come from?: Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.